Cannabis stocks experienced significant volatility following a DEA announcement at 4PM rescheduling cannabis to Schedule III, impacting ETFs like $MSOS which saw a trading halt due to this volatility. The stock $MSOS surged by 24% after the halt. This regulatory change is part of a broader review process expected to last at least six months, involving public comments and hearings.